Status
Conditions
Treatments
About
This is an multicenter, randomized, controlled, parallel group study. ST-Segment Elevation Myocardial Infarction (STEMI) patients with high thrombus burden(HTB) will be allocated to one of the following: intrathrombus thrombolysis or manual aspiration thrombectomy during primary percutaneous coronary intervention(PPCI).
Full description
The hypothesis for ATTRACTIVE trial is that the intrathrombus thrombolysis with microcatheter or pierced balloon compared to manual aspiration thrombectomy will reduce the incidence of major adverse cardiovascular events(MACEs), including cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or heart failure rehospitalization, stent thrombosis and target-vessel revascularization at 1 year in STEMI patients with HTB undergoing PPCI.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients presenting with:
Referred for PPCI
Within 12 hours of symptom onset, or 12-24 hours but still suffered from persistent symptom, hemodynamic instability or fatal arrhythmia
High thrombus burden:
Informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
2,500 participants in 2 patient groups
Loading...
Central trial contact
Zhaoxue Sheng, Doctor; Zhen Zhang, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal